Zhilin Li - 29 Sep 2023 Form 4 Insider Report for CHINA PHARMA HOLDINGS, INC. (CPHI)

Role
CEO & Interim CFO, Director, 10%+ Owner
Signature
/s/Zhilin Li
Issuer symbol
CPHI
Transactions as of
29 Sep 2023
Net transactions value
+$1,925,989
Form type
4
Filing time
19 Oct 2023, 16:06:09 UTC
Previous filing
13 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPHI Common Stock Award $1,925,989 +13,757,063 +996% $0.1400 15,138,063 29 Sep 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 29, 2023, the reporting person was granted 13,757,063 shares of Issuer's common stock pursuant to certain loan settlement agreement with the Company to settle a loan in the amount of $1,854,452.10 that the Company owed to the reporting person.
F2 After giving effect to the 1-for-10 reverse stock split on March 6, 2023, resulting 13,810,000 shares the reporting person previously owned being 1,381,000 shares.